BioNTech gained prominent public attention for its collaboration with Pfizer which produced a COVID-19 vaccine using mRNA technology. They have once again hit the headlines – this time setting their sights on malaria. BioNTech’s malaria project is part of the ‘eradicateMalaria’ initiative, led by the kENUP Foundation, to accelerate the eradication of the mosquito-borne disease. […]
mRNA vaccines
CureVac trials add questions for mRNA vaccines
Following the success stories of the Pfizer and Moderna mRNA vaccines for COVID-19, many thought mRNA vaccines paved the way for the future of immunisation. These theories may be faced with a setback as phase-III trials of fellow mRNA vaccine candidate CureVac has achieved subpar results. CureVac, based in Tübingen, Germany, announced data from the […]